Ralph Hanano

Ralph Hanano currently serves as the Director of Business Development and Chief Marketing Officer (CMO) at Rommelag, where he leverages his extensive expertise in biomedical engineering, biotechnology, and healthcare management to drive strategic growth and innovation. In this pivotal role, Ralph is responsible for identifying and cultivating global partnerships within the pharmaceutical and healthcare sectors, with a particular focus on advancing Rommelag’s cutting-edge aseptic Blow-Fill-Seal (BFS) technology. His deep understanding of medical devices, life sciences, and public health enables him to align Rommelag’s innovative packaging solutions with the evolving needs of pharmaceutical manufacturers, biotech firms, and non-pharmaceutical product companies.

Ralph’s key projects often involve complex interdisciplinary team coordination, ensuring seamless collaboration across R&D, regulatory, and commercial functions to deliver tailored aseptic packaging solutions that meet stringent quality and safety standards. His expertise in project management and communication allows him to navigate the nuances of international markets, fostering long-term relationships built on trust, diplomacy, and mutual respect. Ralph’s strategic initiatives focus on expanding Rommelag’s footprint in emerging markets, enhancing customer engagement through targeted marketing strategies, and exploring new applications of BFS technology in areas such as biologics, vaccines, and sterile liquids.

With a robust skill set encompassing healthcare information technology, medical devices, and public health, Ralph is well-equipped to lead Rommelag’s efforts in advancing sterile liquid packaging solutions that prioritize patient safety, regulatory compliance, and operational efficiency. His leadership not only strengthens Rommelag’s position as an industry innovator but also underscores his commitment to improving healthcare delivery worldwide through innovative packaging technologies.